{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:53:46Z","timestamp":1788144826684,"version":"build-2803163510"},"reference-count":28,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["16\/167\/123"],"award-info":[{"award-number":["16\/167\/123"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>For women with chronic or gestational hypertension who remain well, early term birth (at 37\u201338 weeks\u2019 gestation) may reduce maternal complications, caesareans and stillbirths, but it may increase neonatal morbidity compared with expectant care. Expectant care may increase costs. There are no high-quality data to guide care, which currently involves maternal\u2013fetal surveillance and intervention for maternal or fetal compromise, which may be rapid or unexpected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-2\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate optimal timing of birth for women with chronic or gestational hypertension who reach term and remain well.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-3\">\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Pragmatic, unmasked, multicentre randomised trial with a health economic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-4\">\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Fifty United Kingdom hospitals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-5\">\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Inclusion: maternal age\u2005\u2265\u200516 years, chronic or gestational hypertension, singleton pregnancy, live fetus, 36\n                      <jats:sup>+0<\/jats:sup>\n                      \u201337\n                      <jats:sup>+6<\/jats:sup>\n                      weeks\u2019 gestation and able to give documented informed consent. Exclusion: contraindication to either trial arm (e.g. pre-eclampsia), blood pressure \u2265\u2005160\/110\u00a0mmHg until controlled, major fetal anomaly anticipated to require neonatal care unit admission or participation in another timed birth trial.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-6\">\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>\n                      Planned early term birth at 38\n                      <jats:sup>+0\u20133<\/jats:sup>\n                      weeks\u2019 (intervention) or \u2018usual care at term\u2019 (control, revised from \u2018expectant care until at least 40\n                      <jats:sup>+0<\/jats:sup>\n                      weeks\u2019, August 2022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-7\">\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Maternal coprimary: composite of \u2018poor maternal outcome\u2019 (severe hypertension, maternal death or maternal morbidity and superiority hypothesis).<\/jats:p>\n                    <jats:p>Neonatal coprimary: neonatal care unit admission \u2265\u20054 hours (non-inferiority hypothesis). Each coprimary is measured until primary hospital discharge or 28 days post birth (whichever is earlier).<\/jats:p>\n                    <jats:p>Key secondary: caesarean birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-8\">\n                    <jats:title>Randomisation<\/jats:title>\n                    <jats:p>1\u2005:\u20051 ratio, minimised for key prognostic variables: site, hypertension type and prior caesarean.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-9\">\n                    <jats:title>Blinding<\/jats:title>\n                    <jats:p>It was not possible to mask care providers or participants to the intervention. For the coprimary maternal outcome, there was local site principal investigator\/delegate sign-off based on review, masked to allocated group, of primary case notes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-10\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 2019 to 2022, 403 participants were randomised (37% of target 1080) to intervention (\n                      <jats:italic>n<\/jats:italic>\n                      \u2005=\u2005201) or control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2005=\u2005202). The funder stopped the trial during the coronavirus disease discovered in 2019 pandemic for delayed recruitment. In the intervention (vs. control) group, birth was a median of 0.9 weeks earlier (38.4, interquartile range 38.3\u201338.6 vs. 39.3, interquartile range 38.7\u201339.9 weeks). There was no evidence of a difference in \u2018poor maternal outcome\u2019 (13% vs. 12%, respectively; adjusted risk ratio 1.16, 95% confidence interval 0.72 to 1.87). For \u2018neonatal care unit admission\u2005\u2265\u20054 hours\u2019, the intervention was considered to be non-inferior to control, as the adjusted risk difference, 95% confidence interval upper bound did not cross the 8% pre-specified non-inferiority margin (7% vs. 7%, respectively; adjusted risk difference 0.003, 95% confidence interval \u22120.05 to +0.06), although event rates were lower than estimated. There was no evidence of a difference in caesarean (29% vs. 36%, respectively; adjusted risk ratio 0.81, 95% confidence interval 0.61 to 1.08).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-11\">\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>Recruitment was 37% of the anticipated sample size (as above).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-12\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Despite being unable to recruit to target in this study, we observed that most women with chronic or gestational hypertension required labour induction and planned birth at 38\n                      <jats:sup>0\u20133<\/jats:sup>\n                      weeks (vs. usual care), which resulted in birth an average of 6 days earlier and there were no differences in poor maternal outcome or neonatal morbidity. Our findings provide reassurance about planned birth at 38\n                      <jats:sup>0\u20133<\/jats:sup>\n                      weeks as a clinical option for these women.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-13\">\n                    <jats:title>Future work<\/jats:title>\n                    <jats:p>An individual participant data meta-analysis is planned to address whether the intervention (vs. control) reduces caesarean; low adverse event rates would make unfeasible mounting another randomised trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs1-14\">\n                    <jats:title>Funding<\/jats:title>\n                    <jats:p>This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16\/167\/123.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3310\/aavv3131","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:18:47Z","timestamp":1739938727000},"page":"1-28","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Timing of birth to improve outcomes in chronic or gestational hypertension: the WILL RCT"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-6049","authenticated-orcid":true,"given":"Katie","family":"Kirkham","sequence":"first","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8083-2947","authenticated-orcid":true,"given":"Eleni","family":"Gkini","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0473-0532","authenticated-orcid":true,"given":"Catherine","family":"Moakes","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-4347","authenticated-orcid":true,"given":"Sue","family":"Tohill","sequence":"additional","affiliation":[{"name":"Maternity Services, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-6018","authenticated-orcid":true,"given":"Jennifer A","family":"Hutcheon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-4382","authenticated-orcid":true,"given":"Joel","family":"Singer","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-3221","authenticated-orcid":true,"given":"Jon","family":"Dorling","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-6583","authenticated-orcid":true,"given":"Clive","family":"Stubbs","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4561-8256","authenticated-orcid":true,"given":"Marcus","family":"Green","sequence":"additional","affiliation":[{"name":"Action on Pre-Eclampsia (APEC), Evesham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5095-4231","authenticated-orcid":true,"given":"Mishal","family":"Javed","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-4923","authenticated-orcid":true,"given":"Jesse","family":"Kigozi","sequence":"additional","affiliation":[{"name":"Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-550X","authenticated-orcid":true,"given":"Ben","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Adelaide, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2937-8368","authenticated-orcid":true,"given":"Pollyanna","family":"Hardy","sequence":"additional","affiliation":[{"name":"National Perinatal Epidemiology Unit Clinical Trials Unit, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9764-6876","authenticated-orcid":true,"given":"Jim","family":"Thornton","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4136-3070","authenticated-orcid":true,"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[{"name":"Institute of Women and Children\u2019s Health, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-610X","authenticated-orcid":true,"given":"Laura A","family":"Magee","sequence":"additional","affiliation":[{"name":"Institute of Women and Children\u2019s Health, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2026,1]]},"reference":[{"key":"key2026012013410600_ref1-bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1471-0528.2010.02754.x","article-title":"Optimal timing of delivery in pregnancies with pre-existing hypertension","volume":"118","author":"Hutcheon","year":"2011","journal-title":"BJOG"},{"key":"key2026012013410600_ref2-bib2","doi-asserted-by":"crossref","first-page":"214.e1","DOI":"10.1016\/j.ajog.2012.06.009","article-title":"What is the optimal time for delivery in women with gestational hypertension?","volume":"207","author":"Cruz","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"key2026012013410600_ref3-bib3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1471-0528.2010.02710.x","article-title":"An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial)","volume":"117","author":"Vijgen","year":"2010","journal-title":"BJOG"},{"key":"key2026012013410600_ref4-bib4","article-title":"Induction of labour for improving birth outcomes for women at or beyond term","volume":"6","author":"Gulmezoglu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key2026012013410600_ref5-bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1503\/cmaj.130925","article-title":"Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis","volume":"186","author":"Mishanina","year":"2014","journal-title":"CMAJ"},{"key":"key2026012013410600_ref6-bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1800566","article-title":"Labor induction versus expectant management in low-risk nulliparous women","volume":"379","author":"Grobman","year":"2018","journal-title":"N Engl J Med"},{"key":"key2026012013410600_ref7-bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1523-536X.1997.00214.pp.x","article-title":"Women\u2019s evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. TermPROM Study Group","volume":"24","author":"Hodnett","year":"1997","journal-title":"Birth"},{"key":"key2026012013410600_ref8-bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2005.03.004","article-title":"Women\u2019s perceptions, expectations and satisfaction with induced labour \u2013 a questionnaire-based study","volume":"123","author":"Shetty","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2026012013410600_ref9-bib9","article-title":"Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term","volume":"1","author":"Cluver","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"key2026012013410600_ref11-bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1515\/jpm-2012-0179","article-title":"Management of gestational hypertension \u2013 the impact of HYPITAT","volume":"41","author":"Pauli","year":"2013","journal-title":"J Perinat Med"},{"key":"key2026012013410600_ref12-bib12","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/j.1471-0528.2011.03138.x","article-title":"Impact of the HYPITAT trial on doctors\u2019 behaviour and prevalence of eclampsia in the Netherlands","volume":"118","author":"van der Tuuk","year":"2011","journal-title":"BJOG"},{"key":"key2026012013410600_ref13-bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.preghy.2023.03.002","article-title":"WILL (When to induce labour to limit risk in pregnancy hypertension): protocol for a multicentre randomised trial","volume":"32","author":"Kirkham","year":"2023","journal-title":"Pregnancy Hypertens"},{"key":"key2026012013410600_ref14-bib14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/1471-0528.16319","article-title":"A core outcome set for pre-eclampsia research: an international consensus development study","volume":"127","author":"Duffy","year":"2020","journal-title":"BJOG"},{"key":"key2026012013410600_ref15-bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12884-015-0513-4","article-title":"Childbirth experience questionnaire: validating its use in the United Kingdom","volume":"15","author":"Walker","year":"2015","journal-title":"BMC Pregnancy Childb"},{"key":"key2026012013410600_ref16-bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N Engl J Med"},{"key":"key2026012013410600_ref17-bib17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks\u2019 gestation (HYPITAT): a multicentre, open-label randomised controlled trial","volume":"374","author":"Koopmans","year":"2009","journal-title":"Lancet"},{"key":"key2026012013410600_ref18-bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13063-022-06097-z","article-title":"Planning a method for covariate adjustment in individually randomised trials: a practical guide","volume":"23","author":"Morris","year":"2022","journal-title":"Trials"},{"key":"key2026012013410600_ref19-bib19","volume-title":"NHS Reference Costs 2020\/21","author":"NHS England"},{"key":"key2026012013410600_ref20-bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejogrb.2023.07.021","article-title":"Perinatal and maternal outcomes according to timing of induction of labour: a systematic review and meta-analysis","volume":"288","author":"Jeer","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key2026012013410600_ref21-bib21","article-title":"Induction of labour at or beyond 37 weeks\u2019 gestation","volume":"7","author":"Middleton","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"key2026012013410600_ref22-bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/uog.20224","article-title":"Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis","volume":"53","author":"Bernardes","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"key2026012013410600_ref23-bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajog.2022.04.034","article-title":"Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis","volume":"227","author":"Beardmore-Gray","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"key2026012013410600_ref24-bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1186\/s12884-020-03407-8","article-title":"Immediate versus delayed induction of labour in hypertensive disorders of pregnancy: a systematic review and meta-analysis","volume":"20","author":"Li","year":"2020","journal-title":"BMC Pregnancy Childb"},{"key":"key2026012013410600_ref25-bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.18203\/2320-1770.ijrcog20160567","article-title":"Induction of labour versus conservative management for mild gestational hypertension at term","volume":"5","author":"Bhageerathy","year":"2016","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"key2026012013410600_ref26-bib26","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med"},{"key":"key2026012013410600_ref27-bib27","doi-asserted-by":"crossref","first-page":"2210727","DOI":"10.1080\/14767058.2023.2210727","article-title":"The optimal gestational age to deliver patients with chronic hypertension on antihypertensive therapy","volume":"36","author":"Jeganathan","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key2026012013410600_ref29-bib29","volume-title":"STRIDE: SupporTing Recruitment and Retention Improvements for Diverse Ethnicities","author":"Treweek"},{"key":"key2026012013410600_ref30-bib30","volume-title":"Findings, Conslusions and Essential Actions from the Independent Review of Maternity Services at The Shrewsbury and Telford Hospital NHS Trust","author":"Ockenden Report","year":"2022"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2049600","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/sites\/journalslibrary\/files\/journal_data\/AAVV3131\/AAVV3131.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2049600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:27:46Z","timestamp":1768901266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/AAVV3131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"alternative-id":["10.3310\/AAVV3131"],"URL":"https:\/\/doi.org\/10.3310\/aavv3131","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"06-2018","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"05-2024","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"06-2025","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}